Intermittent Androgen Deprivation for Locally Advanced Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0232|65|1|24-28

ISSN： 0030-2414

Source： Oncology, Vol.65, Iss.1, 2003-09, pp. : 24-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate‐risk, high‐risk, localized, and locally advanced prostate cancer

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1620-1629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Positive and negative mood in men with advanced prostate cancer undergoing androgen deprivation therapy: considering the role of social support and stress

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 8, 2015-08 ,pp. : 932-939

John Wiley & Sons Inc

Access to resources Recommend Favorite

The predictive value of ERG protein expression for development of castration‐resistant prostate cancer in hormone‐naïve advanced prostate cancer treated with primary androgen deprivation therapy

By  

THE PROSTATE, Vol. 75, Iss. 14, 2015-10 ,pp. : 1499-1509

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concept and viability of androgen annihilation for advanced prostate cancer

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2628-2637

John Wiley & Sons Inc

Access to resources Recommend Favorite

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 897-906

John Wiley & Sons Inc

Access to resources Recommend Favorite